Tomoaki Ida Shunsuke Furuta Asuka Takayama Jun Tamura Yuki Hayashi Kazuya Abe Syunjiro Kurihara Junichi Ishikawa Taro Iwamoto Kei Ikeda Kotaro Suzuki Hiroshi Nakajima
10.1136/rmdopen-2022-002795
RMD Open
2023 Jan;9(1):e002795.
cytokines dermatomyositis therapeutics
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36593080/
Dermatomyositis / complications Dermatomyositis / drug therapy Immunosuppressive Agents / adverse effects
Dermatomyositis / complications Dermatomyositis / drug therapy Immunosuppressive Agents / adverse effects Glucocorticoids / therapeutic use Humans Lung Diseases, Interstitial / epidemiology Glucocorticoids Immunosuppressive Agents tofacitinib
PMC9809321
36593080
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
2023